BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 16213674)

  • 1. Candida dubliniensis: ten years on.
    Sullivan DJ; Moran GP; Coleman DC
    FEMS Microbiol Lett; 2005 Dec; 253(1):9-17. PubMed ID: 16213674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida dubliniensis, a new fungal pathogen.
    Gutiérrez J; Morales P; González MA; Quindós G
    J Basic Microbiol; 2002; 42(3):207-27. PubMed ID: 12111748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans.
    Stokes C; Moran GP; Spiering MJ; Cole GT; Coleman DC; Sullivan DJ
    Fungal Genet Biol; 2007 Sep; 44(9):920-31. PubMed ID: 17251042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of the NRG1 repressor controls species-specific regulation of chlamydospore development in Candida albicans and Candida dubliniensis.
    Staib P; Morschhäuser J
    Mol Microbiol; 2005 Jan; 55(2):637-52. PubMed ID: 15659176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of the transcriptional repressor NRG1 accounts for altered host-cell interactions in Candida albicans and Candida dubliniensis.
    Moran GP; MacCallum DM; Spiering MJ; Coleman DC; Sullivan DJ
    Mol Microbiol; 2007 Nov; 66(4):915-29. PubMed ID: 17927699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of strain variation in virulence of Candida dubliniensis and Candida albicans: results of a blinded histopathological study of invasive candidiasis.
    Asmundsdóttir LR; Erlendsdóttir H; Agnarsson BA; Gottfredsson M
    Clin Microbiol Infect; 2009 Jun; 15(6):576-85. PubMed ID: 19604278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular identification of Candida albicans and Candida dubliniensis strains isolated from clinical samples].
    Toraman ZA; Bulut Y; Yilmaz M; Ozdarendeli A
    Mikrobiyol Bul; 2005 Apr; 39(2):199-204. PubMed ID: 16128031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An update on Candida dubliniensis].
    Paugam A; Baixench MT; Viguié C
    Med Mal Infect; 2008 Jan; 38(1):1-7. PubMed ID: 18065177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of phospholipase and proteinase activity in Candida albicans and C. dubliniensis.
    Fotedar R; Al-Hedaithy SS
    Mycoses; 2005 Jan; 48(1):62-7. PubMed ID: 15679669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isogenic strain construction and gene targeting in Candida dubliniensis.
    Staib P; Moran GP; Sullivan DJ; Coleman DC; Morschhäuser J
    J Bacteriol; 2001 May; 183(9):2859-65. PubMed ID: 11292806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Candida dubliniensis in a diagnostic microbiology laboratory.
    Momani OM; Qaddoomi A
    East Mediterr Health J; 2005 May; 11(3):366-71. PubMed ID: 16602455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans.
    Sullivan DJ; Moran GP; Pinjon E; Al-Mosaid A; Stokes C; Vaughan C; Coleman DC
    FEMS Yeast Res; 2004 Jan; 4(4-5):369-76. PubMed ID: 14734017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of the gray phenotype and white-gray-opaque tristable phenotypic transitions in Candida dubliniensis.
    Yue H; Hu J; Guan G; Tao L; Du H; Li H; Huang G
    Virulence; 2016 Apr; 7(3):230-42. PubMed ID: 26714067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic methods and commercial systems for the discrimination between C. albicans and C. dubliniensis.
    Campanha NH; Neppelenbroek KH; Spolidorio DM; Spolidorio LC; Pavarina AC
    Oral Dis; 2005 Nov; 11(6):392-8. PubMed ID: 16269032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology, phylogeny and evolution of Candida albicans.
    McManus BA; Coleman DC
    Infect Genet Evol; 2014 Jan; 21():166-78. PubMed ID: 24269341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Candida dubliniensis: Identification methods and epidemiologic implication].
    Khlif M; Sellami A; Sellami H; Makni F; Ayadi A
    Pathol Biol (Paris); 2011 Jun; 59(3):166-72. PubMed ID: 19046828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida dubliniensis: an emerging opportunistic pathogen.
    Sullivan D; Coleman D
    Curr Top Med Mycol; 1997 Dec; 8(1-2):15-25. PubMed ID: 9504063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative genomics of the fungal pathogens Candida dubliniensis and Candida albicans.
    Jackson AP; Gamble JA; Yeomans T; Moran GP; Saunders D; Harris D; Aslett M; Barrell JF; Butler G; Citiulo F; Coleman DC; de Groot PW; Goodwin TJ; Quail MA; McQuillan J; Munro CA; Pain A; Poulter RT; Rajandream MA; Renauld H; Spiering MJ; Tivey A; Gow NA; Barrell B; Sullivan DJ; Berriman M
    Genome Res; 2009 Dec; 19(12):2231-44. PubMed ID: 19745113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of standard phenotypic assays with a PCR method to discriminate Candida albicans and C. dubliniensis.
    Mähnss B; Stehr F; Schäfer W; Neuber K
    Mycoses; 2005 Jan; 48(1):55-61. PubMed ID: 15679668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid identification of Candida albicans and its related species Candida stellatoidea and Candida dubliniensis by a single PCR amplification using primers specific for the repetitive sequence (RPS) of Candida albicans.
    Kanbe T; Kurimoto K; Hattori H; Iwata T; Kikuchi A
    J Dermatol Sci; 2005 Oct; 40(1):43-50. PubMed ID: 16054340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.